The BlueWind Medical executives and board are united by a common passion for supporting patients around the world who suffer from urge urinary incontinence. Our team comprises seasoned professionals with diverse backgrounds and experience who challenge us not only to create innovative therapies, but also to make positive impacts on society.
Interim Chief Executive Officer & Board Director
Kerry Nelson joined BlueWind Medical as Director in December 2020. She brings expertise in investment and financial management as well as deep experience in investing in medical device companies. Ms. Nelson is currently the Portfolio Manager and Founder of Skystone Capital Management LP, which focuses on the healthcare industry. Before starting her own firm, she was a Portfolio Manager at Highbridge Capital Management, a division of JP Morgan Chase & Co. She spent the previous four years as a Partner with Blum Capital Partners LP, an activist fund, where she spearheaded the firm’s healthcare sector activities. From 1995 to 2001, Ms. Nelson was at Fidelity during which she launched and managed the firm’s Medical Technology Fund. She has previously served as a board observer at Haemonetics (NYSE: HAE) and Kinetics Concepts, Inc. (a division of 3M). Nelson earned a BA from Cornell University.
General Manager & Chief Financial Officer
Stephen Armstrong has a wealth of experience in financial management spanning more than 30 years, with a diverse background in both the healthcare and consumer sectors. Joining BlueWind Medical, he brings his extensive expertise gained from leadership positions in renowned companies such as Medtronic, KPGM Peat Marwick (in International Tax), United Airlines, Pharmacia, and Pfizer. Steve is a certified public accountant and holds a bachelor's degree in International Relations from Claremont McKenna College, as well as a Master's in Management degree from the prestigious J.L. Kellogg Graduate School of Management.
Chief Medical Officer
Dr. Roger Dmochowski is a world-renowned leader in the fields of urology, OAB, and incontinence, a recipient of the Zimskind Award and Lifetime Achievement Awards from the Urodynamics Society for his accomplishments in the clinical treatment for incontinence, a Fellow of the American College of Surgeons, a member of the American Urological Association and International Continence Society, and a trustee of the American Board of Urology. An accomplished scholar, Dr. Dmochowski has published over 320 articles, 100 book chapters, and 460 abstracts, given over 260 presentations at various national and international meetings, led and participated in dozens of OAB and incontinence studies, is the Editor-in-Chief of NeuroUrology and Urodynamics, and serves on the editorial board for several scientific journals.
Chief Technology Officer
Moshe Ben-Chorin has more than 20 years of experience in the high-tech industry. Prior to joining Bluewind Medical, he served as Vice President of the High-Tech Programs at Ramot, the business engagement center of Tel Aviv University. Before that, he served as VP R&D and headed the system engineering group at Aspect Imaging, where he was involved in the development of medical and pre-clinical MRI systems. Prior to that, Moshe held R&D positions at various companies, including being a co-founder and chief scientist of Genoa Color Technologies, where he guided the development of multi-primary display technology from idea to maturation. Moshe holds a Ph.D. in Physics from the Hebrew University of Jerusalem, and spent several years following graduation in academic research. He is an author of about 60 scientific publications and a co-inventor of more than 20 patent families.
Vice President, Medical Affairs and Product Strategy
Dr. Karin Aharonson-Raz is a biomedical scientist, trained as a veterinarian doctor, and holds a Ph.D. in Epidemiology, with a multidisciplinary research background in neuroscience, immunology and epidemiology. She has been in BlueWind Medical from the early stages and was involved as the company transitioned from pre-clinical to clinical phases leading the science research, pre-clinical, clinical and regulatory fields.
Vice President, Operations
Paul Maguire brings more than 25 years of operations experience in medical devices to BlueWind Medical, with a career spanning multinational organizations such as Stryker, Boston Scientific, Medtronic, Allergan, and, most recently, AbbVie. As Executive Director of New Jersey Operations at AbbVie, Paul led a large-scale regenerative medicine business and oversaw major operational transformation programs. Before that, he also managed a startup operation and supply chain for the VenaSeal delivery system for the treatment of varicose veins, supporting the global sales team within Europe, Canada, and the U.S., following the successful completion of a premarket approval application, later to be acquired by Covidien/Medtronic. He holds a Bachelor of Engineering from the Dundalk Institute of Technology and an M.B.A. from the Athlone Institute of Technology.
Vice President, Human Resources
Lisa Mead brings over 30 years of Human Resources experience to BlueWind Medical including 20 years in the healthcare and medical device industry. Prior to joining BlueWind Medical, she was the Head of HR for Silara Medtech Inc., (formerly Direct Flow Medical), where she was responsible for recruitment, organizational development, succession planning, inclusion and diversity, compensation and community and wellness initiatives. Before Silara Medtech, Inc., Lisa worked in London for the National Health Service (NHS), the largest employer in the United Kingdom. She was responsible for talent management, conflict resolution and mediation, and organizational transformation. Lisa has a Bachelor of Science degree in Communication from Emerson University in Boston and an M.B.A. from the University of California, Irvine.
Vice President, Marketing
Sandra Muhlfeld brings 20 years of experience commercializing new medical technologies in both early-stage and large medical device companies. Previously, she held a variety of executive roles at Caldera Medical, a women’s pelvic health medical device company, where she played a key role in building the company from the R&D stage to a high-growth privately held business. Sandra served as the Vice President of Marketing, and most recently she served as the Vice President, Portfolio and Clinical Strategy. Prior to joining Caldera Medical, Sandra held a variety of positions in global and U.S. marketing at Guidant and St. Jude Medical. Sandra holds a B.S. in Physical Therapy from the University of Connecticut and an M.B.A. from the Kellogg School of Management at Northwestern University.
Vice President, Quality
Seamus O’Connor brings 23 years of experience in the medical device industry across quality assurance and regulatory affairs, working with various medical device technologies. His product experience includes life-supporting and sustaining devices, as well as sterile, implantable, and consumable devices. He has successfully managed numerous U.S. Food and Drug Administration inspections and other regulatory body audits. Prior to BlueWind Medical, Seamus held positions of increasing responsibility at MEDNOVA, TE Connectivity, Boston Scientific, and Natus Medical. He holds a Bachelor of Engineering degree and a Higher Diploma in quality management from the University of Galway, Ireland.
Board Chair
Ms. Chmura was appointed to the BlueWind Medical board in September 2024 as the Chair. She is currently Chief Executive Officer and Board Director at Nyra Medical, an innovative medical device company developing a next generation transcatheter mitral valve repair technology. Prior to joining Nyra Medical, she served as Chief Executive Officer, and Board Director at Soundbite Medical Solutions and Dune Medical Devices, where she led the restructuring of both businesses resulting in a cross-border licensing deal at one company, and an acquisition of the other. In addition, Ms. Chmura brings leadership experience in several large multi-national medical device companies, including positions with Medtronic, Covidien and Johnson and Johnson, where she led the growth of the businesses in the United States and globally. She previously served on the Board of Directors as member of the audit committee, and deal team at OpSens Medical. Opsens Medical (TSX- OPS) was acquired in December of 2023 by Haemonetics (NYSE-HAE). She further served on the board of Standard Molecular. Ms. Chmura holds an MBA from Duke University and received her BSN in Nursing from Southern Connecticut State University.
Interim Chief Executive Officer & Board Director
Kerry Nelson joined BlueWind Medical as Director in December 2020. She brings expertise in investment and financial management as well as deep experience in investing in medical device companies. Ms. Nelson is currently the Portfolio Manager and Founder of Skystone Capital Management LP, which focuses on the healthcare industry. Before starting her own firm, she was a Portfolio Manager at Highbridge Capital Management, a division of JP Morgan Chase & Co. She spent the previous four years as a Partner with Blum Capital Partners LP, an activist fund, where she spearheaded the firm’s healthcare sector activities. From 1995 to 2001, Ms. Nelson was at Fidelity during which she launched and managed the firm’s Medical Technology Fund. She has previously served as a board observer at Haemonetics (NYSE: HAE) and Kinetics Concepts, Inc. (a division of 3M). Nelson earned a BA from Cornell University.
Director
Dr. Liz Kwo joined the BlueWind Medical board as a Director in September 2022. Dr. Kwo is currently Chief Medical Officer at Everly Health, a company focused on home care testing. Prior to joining Everly Health, she founded two successful companies: New Pathway Education, a company that provides educational technology throughout China and InfiniteMD, which specializes in connecting international patients to physicians in the US for medical second opinions. Additionally, Dr, Kwo was VP of Provider Networks at American Well, a leading telemedicine company. She also served as Deputy Chief Clinical Officer at Anthem (recently renamed Elevance). Dr. Kwo has an MD from Harvard Medical School, MBA from Harvard Business School, MPH from Harvard TH Chan School of Public Health, and a BA from Stanford University. She is a Board Certified in Preventive Care and Occupational Medicine.
Director
Mr. Neugarten has over 40 years of senior managerial experience, and over 20 years of experience in the medical industry. He brings to BlueWind Medical significant experience in medical devices venture capital investments, commercialization, and asset realization. Mr. Neugarten serves as Executive Chairman of Rainbow Medical, BlueWind’s founder investor, and serves on the boards of Vascular Dynamics, ChroniSense Medical, and Discure Technologies. Mr. Neugarten joined the Viola Partners Group in 2000 as a partner of DOR Ventures, a VC fund focusing on imaging technologies. During his period at DOR Ventures he led various investments including medical imaging ventures. Since 2006, he led the healthcare investments of Viola Partners. Prior to joining the Viola Partners Group, he worked for Scitex (NASDAQ:SCIX) in various management positions in Europe, Japan, and Israel. He received his BSc in Electronics from the Technion, Haifa Israel, and an MBA from Boston University, Brussels Belgium.
Director
Barry joined the BlueWind Medical Board as Director in 2022 and brings over 40 years of diverse experience in the financial industry. He is currently the Director of the Kirsh Family Office and sits on the Board of Directors for many of the Kirsh Group Portfolio companies. He was the founder, CEO and shareholder of the Meridian Value Added Tax (“VAT”) Reclaim Group which became the largest VAT reclaim agency in the world. In 2013, Barry was appointed Chairman of Magal Security Systems Limited and Jetro Holdings Inc., in addition to sitting on the Board of Ki Corporation Limited. Barry is a Charted Accountant in South Africa and a Registered Auditor in the UK. He holds both a Bachelor of Science and a Bachelor of Accounting from the University of Witwatersrand in South Africa.
